1/130
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Pharmacokinetics
what the body does to the drug
Pharmacodynamics
what the drug does to the body
ADME
absorption, distribution, metabolism, excretion
Absorption
The process by which drug molecules gain access to the bloodstream
Distribution
The process by which drugs and their metabolites are moved through out the body
Metabolism
The process by which drugs are chemically changed by the body
Excretion
The process by which drugs and their metabolites are removed from the body
Pharmacokinetics usually occurs during what phase
Pre-clinical testing and phase 1
A drug can fail if it eliminates ___ in the body
quickly
Beyond 24 hours causes a patient to
forget to take the drug
Most people remember to take their medicine
Monday through Friday; taking the weekends off
Dose
Amount of drug administered (molar, mmol, mg)
Dosing interval
Amount of time between drug dose administration
Cmax
The peak plasma concentration
What makes pharmacokinetics useful for us?
There is a direct linear relationship between drug concentration and response, which tells us the that it is predictable
Tmax
The time to reach Cmax (hr)
Volume of distribution
The apparent volume in which a drug is distributed
Concentration
The amount of a drug in a given volume of plasma (mg/L)
Elimination half time (T 1/2)
Time required for the concentration of a drug to decrease by half (hr)
It is important to know where the drug is going in the body because it
Shows us how to monitor the organs for toxicity
Clearance (CL)
The volume of plasma cleared of a drug per unit of time (L/h)
Bioavailability (F)
The fraction of the dose available to the body (usually expressed as a %)
What fluids/tissues can we sample?
Blood, plasma, urine, saliva
Taking ____ levels became an easier form of being tested over blood samples on astronauts
saliva
Why do we look at plasma levels over blood levels?
Blood is a hard fluid to clean up for analysis
You can use plasma concentrations to predict
what is happening in the tissues
As the plasma concentrations decline,
the tissue concentrations will also decline
Most common route of administration
Oral
Absorption phase is when the concentration is
rising
Cmax is where the rate of absorption is ___ to elimination
equal
If you double the dose, the area under the curve will
double
Area under the curve is usually used to calculate the
bioavailability
Rich data
Data around the peak
After 4-5 half lives, you've eliminated about ___% of the drug
90%
Half lives can help us identify
How much of the drug needs to be administered
What is the least common route of administration for absorption?
Intravenously
Who has trouble taking tablets?
Children and elderly
If a drug is an extended release, you cannot
Crush it into smaller pieces so that it'll be easier to take
A drug has to be scored for it to be
Crushed into smaller pieces
Where can you look to see if a drug can be crushed?
Package insert
Does the route of exposure alter the absorption of a drug?
Yes
Why would you use acetaminophen by IV?
It is a way to manage pain without being reliant on opioids
It's better to stay ahead of pain so that
you don't have to chase the pain
What group would use acetaminophen rectally?
Babies and children that run fevers which cause them to vomit
What is the drawback of giving acetaminophen or any drug by a different route?
They will produce different concentration time profiles
What factors influence the release and absorption kinetics of a drug following oral administration of a solid dosage form
Release characteristics of dosage form, physical chemical properties, dissolution of the drug, physiology of GI tract, disease states, drug interactions
Extended release yields a ___ blood level
constant
Dissolution of a drug is useful because a
drug has to be in solution before it can be absorbed into the body
Physical chemical properties of a drug are useful because of the
ionization state, molecular weight, lipophilicity
Molecular weight cutoff is
500 from the GI tract
What kind of diseases can alter absorption in the GI tract?
Crohn's disease, ulcerative colitis, congestive heart failure, diabetes
Most absorption of orally administered drugs takes place in
the small intestine
Once absorbed from the small intestine, drugs will be taken to the
liver
Active transport requires
energy
Influx transporters
Move drugs into the systematic circulation
Efflux transporter
Transporting drugs back to the GI tract/small intestine
Primary sites for first pass metabolism
GI tract and liver
Goal of drug metabolism
Increase molecular weight of drug and make it more polar
Once the drug is metabolized, it is usually considered to be
Inactive
Bioavailability
The amount of drug that reaches the blood
Bioavailability is primarily determined by
physical properties of the drug, formulation, food effects, gastric emptying, transporters, GI system health, enzyme induction, metabolism variation, disease state, route of exposure
Bioavailability of an IV given drug
100%
Bioavailability of a drug given any other route than IV is usually
less than 100%
Relative bioavailability is useful for
Making a generic drug and seeing how it compares to the brand name product
Apparent volume of distribution
relates the amount of drug in the body to the plasma concentration
The apparent volume of distribution is a good indicator of
the extent of a drug distribution into body fluids and tissues
Clearance
Volume of blood from which drug is completely removed from the plasma per unit of time
What factors influence clearance?
Age, disease, drug concentration, liver function, kidney function
The higher the clearance, the shorter the
T ½ (half-life)
Clearance is ____ to each drug
specific
CL=
0.693 x Vd/T 1/2
F=
AUC (oral) x Dose (IV)/ AUC (IV) x Dose (oral)
Volume and half-life are
directly proportional
Key determinants of drug clearance
Metabolism, renal, hepatobiliary, can have CL for each organ
For many drugs, the total body clearance is dependent on
renal and hepatic clearance
Clearance can be a __ or ___ order process
first or zero
Half life
time necessary to eliminate 50% of the drug in the body
One compartment model
Simplest model, first order kinetics, reference compartment plasma, instantaneous distribution, kinetically homogenous unit rapid equilibrium
What types of drugs follow one compartment model?
Drugs with small distribution, more hydrophilic
Drugs with high volume of distribution
Have concentration in tissue rather than in plasma, lipid soluble, distributed into cells
What are the considerations that must be taken into account during dosing?
Therapeutic index, therapeutic range, adverse drug reactions, PK parameters(elimination half life), formulations available, clinical factors, local or systemic effect
Therapeutic range is
where the majority of patients have an optimal response
Therapeutic index
Minimum toxic concentration/minimim therapeutic concentration
Examples of adverse drug reactions
Infused too quickly, GI distress, irritation to skin, bad taste in mouth
Examples of clinical factors regarding dosing
Inherent person to person variability, disease, age and weight, drug-drug interactions
Who is at most risk for drug-drug interactions
The elderly
What could cause variability between subjects?
Renal function, drug-drug interactions, gender, ethnicity
Pharmacogenetics is
The move towards personalized medicine based on genetic testing
3 questions to answer when dealing with dosing regimes?
How much, how long, and how often?
Local effect
eye drops, antibiotic ointment, ear drops
systemic effects
drug administered throughout the body by the bloodstream to internal organs
Very short half life
Less than 20 minutes
Short half life
20 minutes-3 hours
Intermediate half life
3-8 hours
Long half life
8-24 hours
Very long half life
Longer than 24 hours
Types of study designs for bioequivalence
Fasting study, food intervention study, a multiple dose
How long does it take to get to steady state?
4-5 half lives
The Three R's (for animal research)
Reduction, replacement, refinement
Reduction
Any strategy that will result in fewer animals being used in research